NCT04140812 (NEW_STRATEGI) is a NA clinical trial of mass spectrometry (LC-MS/MS) in Preterm Birth, sponsored by University of Erlangen-Nürnberg Medical School.

Who is sponsoring NCT04140812?

NCT04140812 is sponsored by University of Erlangen-Nürnberg Medical School.

What drugs are being tested in NCT04140812?

Interventions in NCT04140812: mass spectrometry (LC-MS/MS).

What condition does NCT04140812 study?

NCT04140812 studies Preterm Birth, Coagulation Protein Disorders, Coagulation Disorder Neonatal.

Is NCT04140812 still recruiting?

NCT04140812 is currently status unknown. Last updated 28 October 2019.

Last reviewed 2019-10-28 · How we verify

NCT04140812: NEW_STRATEGI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stratifying Risk for Intracerebral Haemorrhage

Status unknown NA Last updated 28 October 2019

What this trial tests

NA trial testing mass spectrometry (LC-MS/MS) in Preterm Birth in 50 participants. Status unknown.

Timeline

21 October 2019

Primary endpoint
30 September 2020

30 September 2020

Quick facts

Lead sponsor	University of Erlangen-Nürnberg Medical School
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	50
Start date	21 October 2019
Primary completion	30 September 2020
Estimated completion	30 September 2020
Sites	1 location across Germany

Drugs / interventions tested

mass spectrometry (LC-MS/MS)

Conditions studied

Preterm Birth — all drugs for Preterm Birth →
Coagulation Protein Disorders — all drugs for Coagulation Protein Disorders →
Coagulation Disorder Neonatal — all drugs for Coagulation Disorder Neonatal →

Sponsor

University of Erlangen-Nürnberg Medical School

Who can join

Under 72 Hours, any sex, with Preterm Birth or Coagulation Protein Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigates the role of gestational age on the prevalence of coagulation factors and components of the complement system in preterm- (≤32+0 weeks) and term neonates (≥37+0 weeks) and their role for the development of brain hemorrhage.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Precision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics.
Gavriilaki M, Kimiskidis VK, Gavriilaki E. · · 2020 · cited 21× · PMID 33114553 · DOI 10.3390/ph13110341

Verify or expand the search:

Other recruiting trials for Preterm Birth

Currently open trials in the same condition.

NCT07265583 — Early Prediction of Lung Injury in Preterm Infants Score · recruiting
NCT07305935 — Comparison of Early Caffeine Administration Vs Supportive Therapy in Preventing Acute Kidney Injury · NA · recruiting
NCT07192393 — Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocoliti · recruiting
NCT06826859 — Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH) · Phase 1, PHASE2 · recruiting
NCT07231432 — Promoting Kangaroo Care for Preterm or Low Birthweight Infants in Rural India · NA · active not recruiting

Other University of Erlangen-Nürnberg Medical School trials

Trials by the same sponsor.

NCT06969820 — Establishment and Evaluation of Standardized Clinical, Biological and Imaging Parameters to Assess the Response of LDRT · not yet recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07352540 — Single vs Triple Hyaluronic Acid in Knee Osteoarthritis · Phase 2, PHASE3 · not yet recruiting
NCT07313878 — Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Micros · NA · recruiting
NCT07121985 — Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré S · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04140812 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Erlangen-Nürnberg Medical School
Last refreshed: 28 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04140812.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing